The Division of Neuroscience and Behavior (DNB) promotes research on ways in which neuronal and behavioral systems are influenced by genetic, developmental, and environmental factors in conjunction with alcohol exposure to engender alcohol use disorder (AUD).
Selected Efforts
COGA is a comprehensive research project on the inherited aspects of alcohol use disorder (AUD) with the goal of identifying genes that influence an individual’s risk of developing alcohol problems, and understanding how that risk unfolds across the lifespan.
Integrative Neuroscience Initiative on Alcoholism (INIA)
The INIAstress Consortium is made up of researchers across the country who study alcohol abuse and stress interactions in using cross-species and computational modeling approaches.
The INIA Neuroimmune Consortium is a multi-disciplinary, collaborative research consortium investigating immune and inflammatory pathways in the brain to discover new treatments for alcohol use disorder.
Neurobiology of Adolescent Drinking in Adulthood (NADIA) Consortium
The NADIA Consortium studies the persistent effects of adolescent alcohol exposure on adults and explores the brain mechanisms that are at the root of these effects ultimately to inform and advance social and health care initiatives.
National Consortium on Alcohol and Neurodevelopment in Adolescence - Adulthood (NCANDA-A)
The 5-site NCANDA-A consortium examines effects of alcohol use on the developing adolescent brain, and examines brain characteristics that predict alcohol use problems. The consortium has developed a core battery, including structural and functional brain scans and cognitive testing, for use at all five sites.
To facilitate alcohol-related research, NIAAA is currently supporting the collection of autopsied human brain tissue from individuals with alcohol use disorder and from controls for distribution to qualified alcohol research investigators. Tissue collection and distribution is provided by the Brain Tissue Resource Center (BTRC), University of Sydney, Australia. The goal of the "brain bank" is to provide human brain tissue for the study of the neuropathology, neurobiology and neurogenetics of chronic alcohol consumption.
About the BTRC
BTRC is located in the Discipline of Pathology, University of Sydney, Australia, and is under the direction of Associate Professor Greg Sutherland. The purpose of the BTRC is to collect, characterize and distribute post-mortem human brain tissue to be used by neuroscience researchers for the study of alcohol-related brain disorders1.
To facilitate the collection of human brain tissue by the BTRC, a prospective brain donor program, Using Our Brains, has been established. Through this voluntary program, participants agree to donate their brain to the TRC following their death. Potential donors also undergo annual medical and lifestyle evaluations. This enables the TRC to obtain more accurate and detailed descriptions of the medical histories of the brain tissue collected. Visit the Using Our Brains donor program website for additional information.
Human Tissue for Research
Australian researchers have worked with a substantial population of individuals affected by alcohol use disorder who do not also abuse other drugs, constituting a unique resource for investigators studying alcohol's long term effects on the brain. Since 1985, the BTRC at the University of Sydney has been developing a "brain bank," for which the Center is collecting human brain tissue at autopsy from alcohol-related, malnourished and control cases having confirmed clinical and pathological diagnoses. Diagnoses are confirmed by physician interviews, review of hospital medical records, questionnaires to next-of-kin, and from pathology, radiology and neuropsychology reports.
Investigators interested in alcohol research may submit a request for tissue to the BTRC. Brain tissue may be obtained as either fresh-frozen or formalin-fixed samples.
- Fresh-frozen tissue - At autopsy, one hemisphere is cut into ~10 mm coronal slices and regions of interested dissected; prefrontal cortex, anterior and posterior cingulate cortex, caudate putamen, rostral and caudal thalamus, basal forebrain, hippocampus, amygdala, primary visual cortex, cerebellum, midbrain, pons and medulla. All tissue is then frozen and stored at -80 oC.
- Formalin-fixed tissue – The contralateral hemisphere is fixed in 15% buffered formalin, embedded in agar, and sliced coronally at 3 mm intervals. Blocks of fixed brain tissue are prepared from superior frontal cortex, cingulate gyrus, parietal cortex, temporal cortex, occipital cortex, hippocampus, amygdala, thalamus and hypothalamus, basal ganglia, mamillary body, pons, medulla, cerebellum (lateral) and cerebellum (vermis). These are embedded in paraffin. All cortical blocks contain substantial amounts of white matter. The remaining tissue is stored in buffered formalin.
Further descriptions of the tissue available to investigators include the age, sex, post-mortem delay, pH of tissue and disease classification. Questions and inquiries concerning the BTRC and the availability of brain tissue may be directed through the BTRC website.
Requests for Human Tissue
Requests for brain samples should be directed to the BTRC Manager, Julia Stevens, at +61 2 8627 1668, julia.stevens@sydney.edu.au, or nswbtrc@sydney.edu.au.
To receive tissue, investigators must have IRB or ethics approval for the use of human tissue as required by their parent institution. All tissue requests received by the BTRC are reviewed independently by an external Scientific Advisory Board (SAB). The SAB makes the final recommendation to NIAAA and the BTRC for the distribution of tissue.
Following the SAB recommendation and completion of the Material Transfer Agreement, the BTRC will supply to the investigator the requested tissue and appropriate documentation stripped of all personal identifiers. The Principal Investigator and Research Institution will be responsible for costs incurred for processing the samples e.g. consumables, shipping and compliance with U. S. Customs regulations for the importation of human tissue from foreign countries.
Brain tissue that is received from the BTRC is for the exclusive use of the Principal Investigator, and cannot be redistributed to other researchers without authorization from the BTRC. All material remains the property of the BTRC, and any remaining material must be returned on request. All unused tissue must be returned to the BTRC on completion of the research project.
The BTRC requires that the Principal Investigator provide an annual report of all presentations, disclosures, and publications arising from the use of the materials. The Principal Investigator also agrees to acknowledge the contribution of the Brain Tissue Resource Center (BTRC), and the support of the NIH Grant R28 AA12725 (NIAAA) and other funding agencies in all oral and written presentations, disclosures, and publications resulting from the use of the brain tissue.
References
1. Sheedy, D., Garrick, T., et al. 2008. An Australian brain bank: a critical investment with a high return! Cell Tissue Bank, 9, 205-16.
2. Sutherland, G.,Sheedy, D., et al 2016. The NSW Brain Tissue Resource Centre: Banking for alcohol and major neuropsychiatric disorders research. Alcohol, 52, 33-39.
NIAAA Coordinators
Mark Egli, Ph.D., megli@mail.nih.gov
Director, Division of Neurosciences and Behavior
NIAAA Scientific Advisory Board (SAB) Members
Tatiana Foroud, Ph.D.
P. Michael Conneally Professor of Medical and Molecular Genetics
Chancellor's Professor
Director of Hereditary Genomics Division
Indiana University School of Medicine
Indianapolis, IN
Fulton T. Crews, Ph.D.
Professor and Director
Bowles Center for Alcohol Studies
University of North Carolina at Chapel Hill
Chapel Hill, NC 27599
R. Adron Harris, Ph.D.
Professor and Director
Waggoner Center for Alcohol & Addiction Research
University of Texas
Austin, TX 78713
Staff
| Name | Position | Focus Area* |
|---|---|---|
| Mark D. Egli, Ph.D. | Acting Director | Behavioral Science; Pain and alcohol interactions; Preclinical Therapeutics Discovery |
| Mohammed Akbar, Ph.D. | Program Officer | GPCR Signaling; Metabolism and Stress; Neurodegeneration; Neuroendocrinology; Neuronal Signaling |
| Nagaraja Sethuraman Balakathiresan, Ph.D. | Program Officer | Alcohol Interaction with TBI, PTSD, Psychological Disorders and Depression; Biomarkers; Cellular and Molecular Mechanism of PTSD and TBI |
| Changhai Cui, Ph.D. | Program Officer | Molecular neuroscience; Neurocircuits; Neuroimmune Interactions; Neuromodulation; Neurotechnology; Signaling transduction |
| Ivana Grakalic, Ph.D. | Program Officer | Aggression; Behavioral Control; Comorbidity and Polysubstance Use; Learning & Memory; Women’s health |
| Shailesh Kumar, Ph.D. | Program Officer | Neural and genetic mechanisms of sleep and Alcohol Use Disorder |
| Qi-Ying Liu, M.D., M.S. | Program Officer | Cellular Neurobiology & Neurocircuitry; Neuroadaptation; Neuromodulation; Synaptic Plasticity |
| Dominique Lorang-Leins, Ph.D. | Program Officer | Animal Genetic Models; Genomics and Epigenetics; GxE; Molecular Neurobiology and Genetics |
| Miri Gitik, Ph.D. | Program Officer | GxE; Human Genetics & Genomics; Integrated Genetics/Genomics |
| Elizabeth Powell, Ph.D. | Program Officer | Biomedical Engineering; Computati onal Neuroscience; Data Science; Developmental Neurobiology; Fetal Alcohol Spectrum Disorder (FASD) |